SUSQUEHANNA INTERNATIONAL GROUP, LLP - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 72 filers reported holding LEAP THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$5,091
-62.7%
14,973
-50.6%
0.00%
Q4 2022$13,643
-71.0%
30,317
-42.6%
0.00%
Q3 2022$47,000
-44.7%
52,836
-28.2%
0.00%
Q2 2022$85,000
-67.6%
73,550
-50.8%
0.00%
Q1 2022$262,000
-81.5%
149,500
-65.8%
0.00%
Q4 2021$1,420,000
+3055.6%
437,522
+1421.9%
0.00%
Q1 2020$45,000
+150.0%
28,748
+74.3%
0.00%
Q4 2019$18,000
-94.5%
16,497
-68.4%
0.00%
Q4 2017$326,00052,2320.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Perceptive Advisors 16,952,992$27,802,0000.18%
Opaleye Management Inc. 540,000$886,0000.15%
ACT CAPITAL MANAGEMENT, LLC 134,000$220,0000.11%
Artal Group S.A. 3,000,000$4,920,0000.10%
HHLR ADVISORS, LTD. 3,575,745$5,864,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 910,047$1,492,0000.04%
PERSONAL CFO SOLUTIONS, LLC 78,165$128,0000.03%
GSA CAPITAL PARTNERS LLP 122,401$201,0000.02%
Windsor Creek Advisors, LLC 46,955$77,0000.02%
Golden Green, Inc. 14,824$24,0000.02%
View complete list of LEAP THERAPEUTICS INC shareholders